Assess bleeding risk with HAS-BLED and assess stroke risk with CHA2DS2-VASc in patients with atrial fibrillation.
Centre for Cardiovascular Sciences, City Hospital, University of Birmingham, Birmingham, UK.
Yee C
YC
Lau
Centre for Cardiovascular Sciences, City Hospital, University of Birmingham, Birmingham, UK.
Gregory Yh
GY
Lip
Centre for Cardiovascular Sciences, City Hospital, University of Birmingham, Birmingham, UK.
Pilar
P
Gallego
D001281:Atrial Fibrillation / Q000150:complications*; D002545:Brain Ischemia / Q000209:etiology*; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D020521:Stroke / Q000209:etiology*
D005343:Fibrinolytic Agents